HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor Homing Reactive Oxygen Species Nanoparticle for Enhanced Cancer Therapy.

Abstract
Multifunctional nanoparticles that carry chemotherapeutic agents can be innovative anticancer therapeutic options owing to their tumor-targeting ability and high drug-loading capacity. However, the nonspecific release of toxic DNA-intercalating anticancer drugs from the nanoparticles has significant side effects on healthy cells surrounding the tumors. Herein, we report a tumor homing reactive oxygen species nanoparticle (THoR-NP) platform that is highly effective and selective for ablating malignant tumors. Sodium nitroprusside (SNP) and diethyldithiocarbamate (DDC) were selected as an exogenous reactive oxygen species (ROS) generator and a superoxide dismutase 1 inhibitor, respectively. DDC-loaded THoR-NP, in combination with SNP treatment, eliminated multiple cancer cell lines effectively by the generation of peroxynitrite in the cells (>95% cell death), as compared to control drug treatments of the same concentration of DDC or SNP alone (0% cell death). Moreover, the magnetic core (ZnFe2O4) of the THoR-NP can specifically ablate tumor cells (breast cancer cells) via magnetic hyperthermia, in conjunction with DDC, even in the absence of any exogenous RS supplements. Finally, by incorporating iRGD peptide moieties in the THoR-NP, integrin-enriched cancer cells (malignant tumors, MDA-MB-231) were effectively and selectively killed, as opposed to nonmetastatic tumors (MCF-7), as confirmed in a mouse xenograft model. Hence, our strategy of using nanoparticles embedded with ROS-scavenger-inhibitor with an exogenous ROS supplement is highly selective and effective cancer therapy.
AuthorsHyeon-Yeol Cho, Ahmet Mavi, Sy-Tsong Dean Chueng, Thanapat Pongkulapa, Nicholas Pasquale, Hudifah Rabie, Jiyou Han, Jong Hoon Kim, Tae-Hyung Kim, Jeong-Woo Choi, Ki-Bum Lee
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 11 Issue 27 Pg. 23909-23918 (Jul 10 2019) ISSN: 1944-8252 [Electronic] United States
PMID31252451 (Publication Type: Journal Article)
Chemical References
  • Reactive Oxygen Species
  • SOD1 protein, human
  • Nitroprusside
  • Ditiocarb
  • Superoxide Dismutase-1
Topics
  • Animals
  • Ditiocarb (chemistry, pharmacology)
  • Female
  • Humans
  • MCF-7 Cells
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanoparticles (economics, therapeutic use)
  • Neoplasms, Experimental (drug therapy, metabolism, pathology)
  • Nitroprusside (chemistry, pharmacology)
  • Reactive Oxygen Species (metabolism)
  • Superoxide Dismutase-1 (chemistry, pharmacology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: